Hedge fund ups investment in Boston Scientific, St. Jude Medical http://www.bizjournals.com/twincities/news/2013/01/31/blackrock-hedge-fund-ups-investment-in.html?ana=yfcpc Hedge fund giant BlackRock Inc. is stepping up its investment in medical-device companies, including St. Jude Medical and Boston Scientific. New York-based BlackRock (NYSE: BLK) reported in a regulatory filing on Wednesday tha ...

Gilead Sciences to Buy YM BioSciences for $510 Million http://ca.finance.yahoo.com/q?s=YM.TO%2C+&ql=0 http://www.bloomberg.com/news/2012-12-12/gilead-sciences-to-buy-ym-biosciences-for-510-million.html?cmpid=yhoo Gilead Sciences Inc. (GILD), the world’s biggest maker of AIDS drugs, agreed to buy YM BioSciences Inc. (YMI)for $510 million to obtain the Canadian company’s research in ...

http://www.genengnews.com/gen-news-highlights/new-emd-millipore-reportedly-the-third-largest-investor-in-life-science-tools-r-d/81243672/ Merck KGaA successful completed its $7 billion acquisition of Millipore yesterday and created the new EMD Millipore division. It will be known as Merck Millipore outside the U.S. and Canada. The segment combines Merck’s EMD Chemicals business, located ...

Canada's Valeant Pharmaceuticals agrees to buy rival Medicis for about $2.6B http://www.canadianbusiness.com/article/97267--pharmaceutical-takeover-montreal-based-valeant-to-buy-arizona-s-medicisNEW YORK, N.Y. - Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its positio ...

Biotech M&A at 4-year high as pharma faces expiring patents http://www.reuters.com/article/2012/08/02/us-healthcare-deals-idUSBRE8711H420120802 Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic areas such as cancer, inflammation and autoimmune diseases are proving to b ...